LABD vs. IDNA ETF Comparison
Comparison of Direxion Daily S&P Biotech Bear 3X Shares (LABD) to iShares Genomics Immunology and Healthcare ETF (IDNA)
LABD
Direxion Daily S&P Biotech Bear 3X Shares
LABD Description
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.
Grade (RS Rating)
Last Trade
$5.76
Average Daily Volume
15,699,334
79
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.Grade (RS Rating)
Last Trade
$24.50
Average Daily Volume
22,642
34
Performance
Period | LABD | IDNA |
---|---|---|
30 Days | -3.36% | 0.04% |
60 Days | 6.17% | -1.84% |
90 Days | -9.66% | 3.10% |
12 Months | -75.44% | 33.25% |
14 Overlapping Holdings
Symbol | Grade | Weight in LABD | Weight in IDNA | Overlap | |
---|---|---|---|---|---|
BPMC | C | 1.61% | 1.29% | 1.29% | |
DVAX | A | 0.24% | 1.59% | 0.24% | |
EDIT | F | 0.66% | 0.3% | 0.3% | |
EXEL | A | 1.91% | 5.2% | 1.91% | |
GILD | A | 1.64% | 5.61% | 1.64% | |
INCY | A | 1.51% | 4.49% | 1.51% | |
IOVA | B | 1.07% | 2.72% | 1.07% | |
LGND | A | 1.46% | 2.24% | 1.46% | |
MGNX | C | 0.25% | 0.23% | 0.23% | |
MRNA | F | 1.47% | 1.43% | 1.43% | |
NTLA | F | 0.29% | 0.39% | 0.29% | |
REGN | F | 1.77% | 3.8% | 1.77% | |
SRPT | D | 1.66% | 4.34% | 1.66% | |
XNCR | A | 0.49% | 0.32% | 0.32% |
LABD Overweight 65 Positions Relative to IDNA
Symbol | Grade | Weight | |
---|---|---|---|
BMRN | F | 1.89% | |
BLUE | F | 1.87% | |
VRTX | D | 1.84% | |
SAGE | F | 1.8% | |
UTHR | A | 1.78% | |
AMGN | C | 1.75% | |
ALNY | C | 1.73% | |
EXAS | A | 1.73% | |
ABBV | A | 1.72% | |
ACAD | F | 1.68% | |
BIIB | F | 1.65% | |
IONS | F | 1.64% | |
NBIX | C | 1.62% | |
RARE | D | 1.49% | |
ARWR | F | 1.45% | |
BHVN | B | 1.42% | |
PTCT | B | 1.4% | |
FOLD | B | 1.38% | |
AGIO | B | 1.37% | |
APLS | F | 1.24% | |
ALKS | F | 1.21% | |
MYGN | F | 1.08% | |
NTRA | B | 1.08% | |
FGEN | F | 1.05% | |
RGNX | F | 1.05% | |
CHRS | F | 0.99% | |
EBS | B | 0.96% | |
CDNA | D | 0.93% | |
HRTX | F | 0.84% | |
INSM | D | 0.81% | |
KPTI | C | 0.79% | |
ESPR | C | 0.79% | |
ALLK | B | 0.76% | |
IRWD | F | 0.75% | |
VCYT | A | 0.72% | |
HALO | B | 0.71% | |
FATE | F | 0.67% | |
PBYI | C | 0.65% | |
MDGL | A | 0.59% | |
TGTX | A | 0.55% | |
ADVM | D | 0.55% | |
ALLO | D | 0.54% | |
CPRX | A | 0.53% | |
ANAB | F | 0.53% | |
SGMO | A | 0.48% | |
ENTA | D | 0.47% | |
EGRX | F | 0.42% | |
GTHX | A | 0.42% | |
ATRA | C | 0.41% | |
VKTX | A | 0.38% | |
ANIK | F | 0.37% | |
VNDA | D | 0.35% | |
OPK | C | 0.35% | |
VCEL | D | 0.34% | |
TVTX | B | 0.33% | |
KOD | B | 0.29% | |
BBIO | D | 0.29% | |
PGEN | F | 0.29% | |
DNLI | C | 0.28% | |
KRYS | C | 0.28% | |
GOSS | F | 0.27% | |
VYGR | C | 0.26% | |
ALEC | D | 0.25% | |
CYTK | F | 0.25% | |
YMAB | A | 0.24% |
LABD Underweight 20 Positions Relative to IDNA
LABD: Top Represented Industries & Keywords
IDNA: Top Represented Industries & Keywords